Patients Coming Off Weight-Loss Jabs Regain Weight Far More Rapidly Than Dieters

Fresh analysis indicates that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro can put back on shed pounds far faster than those who end conventional diet and exercise plans.

Published data in a leading health publication demonstrates that while obese people frequently drop substantial amounts of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing such drugs need to be informed of the risk of quick weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.

That rate of regain suggests a return to starting mass within about 18 months.

Analyzing Therapies

The study, which examined 37 of trials involving thousands of patients, compared the outcomes of the injectable medications with other pills.

Researchers point out that people who lose weight through lifestyle changes alone generally have a more gradual weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Rapid Regain

Doctors suggest the way of the drugs is key to understanding the heightened regain.

The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this hormone supplement means hunger is no longer kept in check, making excessive eating much more probable."

A Chronic Disease?

Medical guidelines recommend the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.

Professionals argue that, given the high risk of relapse, the therapy is often long-term.

This opinion is supported by drug manufacturers, who say that the results "underscore the chronic character of excess weight," akin to managing diseases like high blood pressure.

Patient Testimonies

Individuals who have stopped the medication describe a intense resurgence of hunger.

"It was like a switch that goes on and you're instantly starving," described an individual.

This challenge is compounded if patients have not adopted sustainable dietary or behavioural changes during treatment.

Significant Use

Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with desire being substantial.

• Adoption is higher among women than men.
• The middle-aged demographic shows the highest usage rates.
• A large proportion obtain the drugs through private healthcare rather than public health services.

Finally, clinicians caution that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent solution and maintained weight loss relies on integrated behavioural changes.